Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016
Open accessThe DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Stimulants are considered the first-line treatment for Attention Deficit Hyperactivity Disorder (ADHD) in the US and they are used in other indications. Stimulants are also diverted for non-medical purposes. Ethnic and regional differences in ADHD diagnosis and in stimulant use have been identified in earlier research. The objectives of this report were to examine the pharmacoepidemiological pattern of these controlled substances over the past decade and to conduct a regional analysis. METHODS: Data (drug weights) reported to the US Drug Enforcement Administration's Automation of Reports and Consolidated Orders System for four stimulants (amphetamine, methylphenidate, lisdexamfetamine, and methamphetamine) were obtained from 2006 to 2016 for Unites States/Territories. Correlations between state level use (mg/person) and Hispanic population were completed. RESULTS: Amphetamine use increased 2.5 fold from 2006 to 2016 (7.9 to 20.0 tons). Methylphenidate use, at 16.5 tons in 2006, peaked in 2012 (19.4 tons) and subsequently showed a modest decline (18.6 tons in 2016). The consumption per municipality significantly increased 7.6% for amphetamine and 5.5% for lisdexamfetamine but decreased 2.7% for methylphenidate (all p < .0005) from 2015 to 2016. Pronounced regional differences were also observed. Lisdexamfetamine use in 2016 was over thirty-fold higher in the Southern US (43.8 mg/person) versus the Territories (1.4 mg/person). Amphetamine use was about one-third lower in the West (48.1 mg/person) relative to the Northeastern (75.4 mg/person, p < .05) or the Midwestern (69.9 mg/person, p ≤ .005) states. States with larger Hispanic populations had significantly lower methylphenidate (r(49) = -0.63), lisdexamfetamine (B, r(49) = -0.49), and amphetamine (r(49) = -0.43) use. CONCLUSIONS: Total stimulant usage doubled in the last decade. There were dynamic changes but also regional disparities in the use of stimulant medications. Future research is needed to better understand the reasons for the sizable regional and ethnic variations in use of these controlled substances.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Diagnostic and Statistical Manual of Mental Disorders, 5th ed.
Carter, M. J. (2014) · Therapeutic Recreation Journal · Cited by 15,169
Johnston, L. D., O'Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2009) · PsycEXTRA Dataset · doi:10.1037/e560352009-001 · Cited by 6,921
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886
Subcommittee on Attention-Deficit/Hyperactivity Disorder, S. C. O. Q. I. A. M. (2011) · Pediatrics · doi:10.1542/peds.2011-2654 · Cited by 2,185
Castellanos, F. X. (2002) · JAMA · doi:10.1001/jama.288.14.1740 · Cited by 1,646
Health Care Spending in the United States and Other High-Income Countries
Papanicolas, I., Woskie, L. R., & Jha, A. K. (2018) · JAMA · doi:10.1001/jama.2018.1150 · Cited by 1,626
Prevalence of Obesity and Severe Obesity in US Children, 1999–2016
Skinner, A. C., Ravanbakht, S. N., Skelton, J. A., Perrin, E. M., & Armstrong, S. C. (2018) · Pediatrics · doi:10.1542/peds.2017-3459 · Cited by 1,412
Visser, S. N., Danielson, M. L., Bitsko, R. H., Holbrook, J. R., Kogan, M. D., Ghandour, R. M., Perou, R., & Blumberg, S. J. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.09.001 · Cited by 1,263
Danielson, M. L., Bitsko, R. H., Ghandour, R. M., Holbrook, J. R., Kogan, M. D., & Blumberg, S. J. (2018) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2017.1417860 · Cited by 1,181
Research works printed but not linked: 1
- G Jachimowicz, 2004, Comparison of ease of falsification of Attention Deficit Hyperactivity Disorder diagnosis using standard behavioral rating scales, Cognitive Science Online, 2, 6
Cited by
ADHD: Current Concepts and Treatments in Children and Adolescents
Drechsler, R., Brem, S., Brandeis, D., Grünblatt, E., Berger, G., & Walitza, S. (2020) · Neuropediatrics · doi:10.1055/s-0040-1701658 · Cited by 415
Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder: A Review
Paulus, M. P., & Stewart, J. L. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.0246 · Cited by 310
Garcia-Romeu, A., Davis, A. K., Erowid, E., Erowid, F., Griffiths, R. R., & Johnson, M. W. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00955 · Cited by 157
Danielson, M. L., Holbrook, J. R., Bitsko, R. H., Newsome, K., Charania, S., McCord, R. F., Kogan, M. D., & Blumberg, S. J. (2022) · Journal of Attention Disorders · doi:10.1177/10870547221099961 · Cited by 88
Neurodevelopmental Disorders: Past, Present, and Future
Cainelli, E., & Bisiacchi, P. S. (2022) · Children · doi:10.3390/children10010031 · Cited by 87
Board, A. R., Guy, G., Jones, C. M., & Hoots, B. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108297 · Cited by 79
“Recent analyses suggest that age, sex, and U.S. state of residence play a role in stimulant prescribing patterns (Burcu et al., 2016; Piper et al., 2018; Safer, 2016; Tseregounis et al., 2019), with stimulant sales to adults surpassing those of children, and adult women receiving more prescription…”
BackgroundDaniulaityte, R., Silverstein, S. M., Crawford, T. N., Martins, S. S., Zule, W., Zaragoza, A. J., & Carlson, R. G. (2020) · Substance Use & Misuse · doi:10.1080/10826084.2020.1765805 · Cited by 71
Huang, X., Harris, L. M., Funsch, K. M., Fox, K. R., & Ribeiro, J. D. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02173-9 · Cited by 49
Mental Health Information Seeking Online: A Google Trends Analysis of ADHD
Zhao, X., Coxe, S. J., Timmons, A. C., & Frazier, S. L. (2021) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-021-01168-w · Cited by 48
Handelman, K., & Sumiya, F. M. (2022) · Brain Sciences · doi:10.3390/brainsci12080959 · Cited by 46
Massuti, R., Maia, C. R. M., Campani, F., Sônego, M. L., Amaro, J., Akutagava‐Martins, G. C., Tessari, L., Polanczyk, G. V., Cortese, S., & Rohde, L. A. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.001 · Cited by 45
LaBossier, N. J., & Hadland, S. E. (2022) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2022.101265 · Cited by 44
Brumbaugh, S., Tuan, W., Scott, A. R., Latronica, J. R., & Bone, C. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101524 · Cited by 40
Medical, Nonmedical, and Illegal Stimulant Use by Sexual Identity and Gender
Philbin, M. M., Greene, E., Martins, S. S., LaBossier, N. J., & Mauro, P. M. (2020) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2020.05.025 · Cited by 38
Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
Boesen, K., Paludan‐Müller, A. S., Gøtzsche, P. C., & Jørgensen, K. J. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012857.pub2 · Cited by 37
Health(care) in the Crisis: Reflections in Science and Society on Opioid Addiction
Damiescu, R., Banerjee, M., Lee, D. Y. W., Paul, N. W., & Efferth, T. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18010341 · Cited by 34
Chemokines, cytokines and substance use disorders
Ahearn, O., Watson, M. N., & Rawls, S. M. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108511 · Cited by 33
Mykletun, A., Widding‐Havneraas, T., Chaulagain, A., Lyhmann, I., Bjelland, I., Halmøy, A., Elwert, F., Butterworth, P., Markussen, S., Zachrisson, H. D., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-041698 · Cited by 30
Gaps and barriers in drug and alcohol treatment following implementation of the affordable care act
Tomko, C. A., Olfson, M., & Mojtabai, R. (2022) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2022.100115 · Cited by 29
Trends in substance use disorder diagnoses among Veterans, 2009–2019
Hoggatt, K. J., Chawla, N., Washington, D. L., & Yano, E. M. (2023) · American Journal on Addictions · doi:10.1111/ajad.13413 · Cited by 29
Houghton, R., de Vries, F., & Loss, G. J. (2019) · CNS Drugs · doi:10.1007/s40263-019-00686-4 · Cited by 28
Piper, B. J., McCall, K. L., Kogan, L. R., & Hellyer, P. W. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.615646 · Cited by 24
Self-citationBoesen, K., Saiz, L. C., Erviti, J., Storebø, O. J., Gluud, C. N., Gøtzsche, P. C., & Jørgensen, K. J. (2017) · BMJ Evidence-Based Medicine · doi:10.1136/ebmed-2017-110716 · Cited by 23
McCabe, S. E., Figueroa, O., McCabe, V. V., Schepis, T. S., Schulenberg, J. E., Veliz, P. T., Werner, K. S., & Wilens, T. E. (2024) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13807 · Cited by 22
Socioeconomic status and prescribing of ADHD medications: a study of ICB-level data in England
Khan, M. U., & Hasan, S. S. (2025) · BMJ Mental Health · doi:10.1136/bmjment-2024-301384 · Cited by 21
Moustafa, Y., Chauhan, M., & Rummans, T. A. (2022) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2022.02.026 · Cited by 20
Over time prevalence of illicit substance use in Saudi Arabia
Alfaifi, A., & El‐Setouhy, M. (2022) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2022.9525150 · Cited by 20
Suhr, J. A., Lee, G. J., & Harrison, A. G. (2020) · The Clinical Neuropsychologist · doi:10.1080/13854046.2020.1817564 · Cited by 20
Exploring the use of cognitive enhancement substances among Portuguese university students
Cavaco, A. M. D. N., Ribeiro, J., & Nørgaard, L. S. (2021) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2021.100097 · Cited by 20
Impact of marijuana legalization on cannabis-related visits to the emergency department
Tolan, N. V., Terebo, T., Chai, P. R., Erickson, T. B., Hayes, B. D., Uljon, S., Petrides, A. K., Demetriou, C. A., & Melanson, S. E. F. (2021) · Clinical Toxicology · doi:10.1080/15563650.2021.2012576 · Cited by 20
Zhao, X., Hayes, T., Timmons, A. C., Wu, W., & Frazier, S. L. (2023) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-023-01259-w · Cited by 19
Is Attention-Deficit/Hyperactivity Disorder a Risk Syndrome for Parkinson’s Disease?
Baumeister, A. A. (2021) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000283 · Cited by 19
Are Amphetamines Associated with Adverse Cardiovascular Events Among Elderly Individuals?
Latronica, J. R., Clegg, T. J., Tuan, W., & Bone, C. (2021) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2021.06.210228 · Cited by 19
McBride, M., Appling, C. B., Ferguson, B. J., Gonzalez, A., Schaeffer, A., Zand, A., Wang, D., Sam, A., Hart, E. S., Tosh, A. K., et al. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05970-0 · Cited by 17
Behavioral, Neurochemical and Developmental Effects of Chronic Oral Methylphenidate: A Review
Senior, D., Ahmed, R., Arnavut, E., Carvalho, A. T. P., Lee, W. X., Blum, K., Komatsu, D. E., Hadjiargyrou, M., Badgaiyan, R. D., & Thanos, P. K. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13040574 · Cited by 16
Najib, J. S., Didenko, E., Meleshkina, D., Yusupov, K., Maw, K., Ramnarain, J., & Tabassum, M. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1815002 · Cited by 16
Levy, N. S., Palamar, J. J., Mooney, S. J., Cleland, C. M., & Keyes, K. M. (2022) · Annals of Epidemiology · doi:10.1016/j.annepidem.2021.12.013 · Cited by 16
Methamphetamine-associated pulmonary arterial hypertension
Kolaitis, N. A., Saggar, R., & Marco, T. D. (2022) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000888 · Cited by 16
Vaddadi, S., Czelatka, N., Gutierrez, B. D., Maddineni, B., Torres-Teran, C. D., Tron, D. N., McCall, K. L., & Piper, B. J. (2021) · PeerJ · doi:10.7717/peerj.12619 · Cited by 14
Self-citationQian, Y., & Markowitz, J. S. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000823 · Cited by 14
Medicalization of Grief: Its Developments and Paradoxes
Wada, K. (2022) · Springer eBooks · doi:10.1007/978-3-030-12852-4_36-1 · Cited by 14
Xu, Y., Towe, S. L., Causey, S. T., Dennis, P. A., & Meade, C. S. (2020) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000423 · Cited by 13
Antoniou, T., McCormack, D., Kitchen, S. A., PAJER, K. A., Gardner, W. P., Lunsky, Y., Penner, M., Tadrous, M., Mamdani, M., Juurlink, D. N., et al. (2023) · BMC Public Health · doi:10.1186/s12889-022-14677-6 · Cited by 13
Predictors of Prescription Stimulant Misuse in U.S. College Graduates
Holt, L. J., & McCarthy, M. D. (2019) · Substance Use & Misuse · doi:10.1080/10826084.2019.1692867 · Cited by 13
Treatment with stimulants and the risk of COVID-19 complications in adults with ADHD
Tuan, W., Babinski, D. E., Rabago, D., & Zgierska, A. E. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.07.005 · Cited by 13
Pronounced Declines in Meperidine in the US: Is the End Imminent?
Harrison, L. R., Arnet, R. E., Ramos, A. S., Chinga, P. A., Anthony, T. R., Boyle, J. M., McCall, K. L., Nichols, S. D., & Piper, B. J. (2022) · Pharmacy · doi:10.3390/pharmacy10060154 · Cited by 13
Self-citationAnalysis of Pharmaceutical Industry Marketing of Stimulants, 2014 Through 2018
Hadland, S. E., Cerdá, M., Earlywine, J. J., Krieger, M. S., Anderson, T. S., & Marshall, B. D. L. (2020) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2019.5526 · Cited by 12
Oladapo, A., Deshetty, U. M., Callen, S. E., Buch, S. J., & Periyasamy, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020649 · Cited by 11
Vosburg, S. K., Faraone, S. V., Newcorn, J. H., Rostain, A. L., Findling, R. L., Butler, S. F., Dailey-Govoni, T., & Green, J. L. (2020) · Journal of Attention Disorders · doi:10.1177/1087054720943283 · Cited by 11
Rorabaugh, B. R. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.652634 · Cited by 12
Ali, M. M., McClellan, C. B., Mutter, R. L., & Rees, D. I. (2022) · Health Economics · doi:10.1002/hec.4620 · Cited by 11
Meng, L.-C., Leonard, C. E., Candon, M. K., Mandell, D. S., & Hennessy, S. (2025) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2025.12.006 · Cited by 10
Prescribed stimulant medications: Trends in the last decade, pre and post COVID-19 response
Kim, M. L., Dalvi, N., Valerio, D. D., Strickler, G. K., & Young, L. D. (2023) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2023.100314 · Cited by 10
Age- and Sex-Specific Increases in Stimulant Prescribing Rates—California, 2008-2017
Tseregounis, I. E., STEWART, S. L., Crawford, A., Marshall, B. D. L., Cerdá, M., Shev, A. B., & Henry, S. G. (2019) · Journal of Attention Disorders · doi:10.1177/1087054719883008 · Cited by 10
Vosburg, S. K., Robbins, R. S., Antshel, K. M., Faraone, S. V., & Green, J. L. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.631792 · Cited by 10
Stimulant Induced Movement Disorders in Attention Deficit Hyperactivity Disorder
Nam, S.-H., Lim, M. H., & Park, T. W. (2022) · Journal of korean Academy of Child and Adolescent Psychiatry · doi:10.5765/jkacap.210034 · Cited by 10
Kalinowski, L., Connor, C., Somanesan, R., Carias, E., Richer, K., Smith, L. C., Martin, C. D., Mackintosh, M., Popoola, D. O., Hadjiargyrou, M., et al. (2019) · Developmental Psychobiology · doi:10.1002/dev.21902 · Cited by 10
Zeng, K., Yu, X., Wei, Z., Wu, Y., Wang, J., Liu, R., Li, Y., & Wang, X. (2023) · General Psychiatry · doi:10.1136/gpsych-2023-101057 · Cited by 9
Rising Stimulant Overdoses Among Young People in the United States
Hadland, S. E., & Marshall, B. D. L. (2020) · PEDIATRICS · doi:10.1542/peds.2020-031526 · Cited by 9
Pediatric ADHD Medication Errors Reported to United States Poison Centers, 2000 to 2021
DeCoster, M., Spiller, H. A., Badeti, J., Casavant, M. J., Rine, N. I., Michaels, N. L., Zhu, M., & Smith, G. A. (2023) · PEDIATRICS · doi:10.1542/peds.2023-061942 · Cited by 8
Stimulant Drugs and Stimulant Use Disorder
Song, W., Simona, A., Zhang, P., Bates, D. W., & Urman, R. D. (2023) · Anesthesiology Clinics · doi:10.1016/j.anclin.2023.09.003 · Cited by 8
Arnavut, E., Hamilton, J., Yao, R., Sajjad, M., Hadjiargyrou, M., Komatsu, D. E., & Thanos, P. K. (2022) · Synapse · doi:10.1002/syn.22243 · Cited by 8
Yager, J., Ritvo, A. D., & MacPhee, E. R. (2022) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000001548 · Cited by 7
Central Nervous System Stimulants in Recreational and Medical Use
Dodd, S., Ospina‐Pinillos, L., & Markowitz, J. S. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009585330.009 · Cited by 7
Ophir, Y., & Rosenberg, H. (2026) · Humanities and Social Sciences Communications · doi:10.1057/s41599-025-06441-z · Cited by 7
Witrick, B., Zhang, D. “., Su, D., Li, Y., McCall, W. V., Hendricks, B. M., & Shi, L. (2023) · Journal of General Internal Medicine · doi:10.1007/s11606-023-08075-w · Cited by 7
Stimulant Medication Use and Risk of Psychotic Experiences
O’Hare, K., Byrne, J. F., Ramsay, H., Romaniuk, L., McGrath, J., Keating, D., Migone, M., O’Connor, K., Coss, N., Cannon, M. D., et al. (2025) · PEDIATRICS · doi:10.1542/peds.2024-069142 · Cited by 7
Søndergaard, N. R., Nørøxe, K. B., Carlsen, A. H., Randing, S. H., Warrer, P., Thomsen, P. H., & Clausen, L. (2024) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2023.0077 · Cited by 7
Perspectives of US Adolescents on Diverted Stimulant Use
Hadler, N. L., Strome, A. L., Waselewski, M. E., Herbert, K., Harper, C., & Chang, T. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.04.010 · Cited by 7
dos Santos, M. I., Neres, J. P. G., Lemos, A. E. O., Cazuza, E. P., dos Santos, E. C. G., & de Melo, M. M. A. (2021) · ARCHIVES OF HEALTH INVESTIGATION · doi:10.21270/archi.v11i3.5570 · Cited by 6
Alqifari, S. F., Aldawish, R., Binsaqr, M. A., Khojah, A. A., Alshammari, M. R., Esmail, A. K., & AL‐Rasheedi, M. (2022) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2022.9525130 · Cited by 6
Turpin, M. A. C., Rowland, K. C., Anugwom, C., Arocha, M., Carona, A., Gonzalez, B. I., Iskander, G., Snyder, S., Wilson, K., Kaye, A. D., et al. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98814-8.00027-5 · Cited by 6
The Univocity of Attention: ADHD and the Case for a Renewed Self-Advocacy
Brown, A. I. (2023) · York University Digital Library (York University) · Cited by 6
Bright, U., Overstreet, C. M., Levey, D. F., & Gelernter, J. E. (2025) · Psychological Medicine · doi:10.1017/s0033291725101293 · Cited by 5
Philbin, M. M., Mauro, P. M., Greene, E., LaBossier, N. J., Giovenco, D. P., & Martins, S. S. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2020.102861 · Cited by 5
Kindt, H. M., Tuan, W., & Bone, C. (2023) · Family Practice · doi:10.1093/fampra/cmac153 · Cited by 5
Providers, Places, and Children’s Mental Health Care
Swagel, G. (2026) · The Journal of Human Resources · doi:10.3368/jhr.0925-14511r1 · Cited by 5
Assessing TDApp: An AI-based clinical decision support system for ADHD treatment recommendations
Baykova, E., Raya, Ò., Lombardía, C., Gonzalvo, B., Andreu, I., Losada, D., Falkenhain, T., Cunill, R., Serrano, D., Comas, D. R., et al. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1582746 · Cited by 5
Prevalence and socioeconomic factors in the prescription of concurrent amphetamine and alprazolam
Zarkowski, P. A., Van-Den-Ende, A. R., & Groen, J. A. (2020) · The International Journal of Psychiatry in Medicine · doi:10.1177/0091217420960619 · Cited by 5
Adverse psychocutaneous effects of prescription stimulant use and abuse: A systematic review
Moattari, C. R., & França, K. (2022) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14669 · Cited by 5
Lopera, S. D., O’Kane, V. M., Goldhirsh, J. L., & Piper, B. J. (2023) · Journal of Attention Disorders · doi:10.1177/10870547231177467 · Cited by 5
Self-citationRisk Factors for Adverse Cardiac Events in Individuals Prescribed Stimulants Across the Lifespan
Groff, D., Tuan, W., Holt, K., Latronica, J. R., & Bone, C. (2025) · Journal of Attention Disorders · doi:10.1177/10870547251313880 · Cited by 4
Amphetamines: a current epidemic
Miller, N. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1460341 · Cited by 4
Initiation Patterns and Transitions Among Adults Using Stimulant Drugs: Latent Transition Analysis
Black, J. C., Burkett, H. L., Rockhill, K. M., Olson, R. A., Dart, R. C., & Iwanicki, J. L. (2023) · Journal of Medical Internet Research · doi:10.2196/46747 · Cited by 4
Diaz, J. E., Ghanooni, D., Atkins, L., Sam, S. S., Kantor, R., Miller-Perusse, M., Chuku, C. C., Valentin, O., Balise, R. R., Davis-Ewart, L., et al. (2024) · AIDS and Behavior · doi:10.1007/s10461-024-04453-5 · Cited by 4
Miola, A., Ercis, M., Pazdernik, V., Salgado, M. F., Ortiz‐Orendain, J., Gardea‐Resendez, M., Gruhlke, P. M., Michel, I. M., Bostwick, J. M., McKean, A. J. S., et al. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.07.015 · Cited by 4
Short Term Methylphenidate Treatment Does Not Increase Myocardial Injury in the Ischemic Rat Heart
Seeley, S. L., D’Souza, M. S., Stoops, T. S., & Rorabaugh, B. R. (2020) · Physiological Research · doi:10.33549/physiolres.934368 · Cited by 4
Psychosocial Motivators of “Smart Drug” Use Amongst University Students
Dempsey, R. C. (2020) · Springer eBooks · doi:10.1007/978-981-15-6771-1_2 · Cited by 4
Time, Schedules, and the College Student with ADHD
Rodriguez, E. D. (2020) · Syracuse University Libraries (Syracuse University) · Cited by 4
Central nervous system stimulants and drugs that suppress appetite
Bello, N. T., & Kshatriya, D. (2019) · Side effects of drugs annual · doi:10.1016/bs.seda.2019.10.001 · Cited by 4
Shen, D., Jiao, J., Zhang, L., Liu, Y., Liu, X., Li, Y., Zhang, T., Li, D., & Hao, W. (2024) · JMIR Serious Games · doi:10.2196/56978 · Cited by 3
Evolution of methylphenidate prescriptions in the region of Occitanie, France, from 2013 to 2021
Velay, A., Alexis, J., Papinaud, L., Domerg, C., Purper‐Ouakil, D., Willig, T.-N., & Kerbage, H. (2025) · L Encéphale · doi:10.1016/j.encep.2025.01.005 · Cited by 3
Diianni, A. T., Davis, L. C., & Piper, B. J. (2025) · BMJ Mental Health · doi:10.1136/bmjment-2025-301913 · Cited by 3
Self-citationUhl, G. R. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1031283 · Cited by 3
Macmadu, A., Banks, A. J., Hallowell, B. D., Scagos, R. P., Hadland, S. E., Chambers, L. C., & Marshall, B. D. L. (2023) · Substance Use & Misuse · doi:10.1080/10826084.2023.2212037 · Cited by 3
Alsberge, J. B., Lee, D. Y., & Jumper, J. M. (2022) · American Journal of Ophthalmology Case Reports · doi:10.1016/j.ajoc.2022.101482 · Cited by 3
Stimulant use by athletes: The role of sports psychiatry
Schneeberger, A. R., Thackaberry, J., Sietsma, A. C., Ashbrook, C., & Koh, S. (2022) · Sports Psychiatry · doi:10.1024/2674-0052/a000027 · Cited by 3
Wortzel, J. R., Turner, B. E., Weeks, B. T., Fragassi, C., Ramos, V., Truong, T., Li, D., Sahak, O., & O’Connor, T. G. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248898 · Cited by 3
Alzahrani, K. M., Faydh, J. A., Althuwaybi, S. E., Dakhil, S. S. F., Althobaiti, F. D. A., & Althagafi, B. (2022) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2022.9525132 · Cited by 3
Abulez, D. S., Brown, C. C., Cucciare, M. A., & Hayes, C. J. (2024) · Substance Use Research and Treatment · doi:10.1177/29768357241274483 · Cited by 2
Metadata
- Authors
- Piper, B. J., Ogden, C. L., Simoyan, O. M., Chung, D. Y., Caggiano, J. F., Nichols, S. D., & McCall, K. L.
- Affiliations
- Geisinger College of Health Sciences (US)
- Tufts University (US)
- University of New England (US)
- Corresponding author
- Piper, Brian J.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-11-28
- Volume
- 13
- Issue
- 11
- Pages
- e0206100
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6261411
- OpenAlex
- W2903069810
- Cited by
- 170
- References
- 85
- Citations by year
- 2026: 8 · 2025: 23 · 2024: 15 · 2023: 27 · 2022: 42 · 2021: 24 · 2020: 23 · 2019: 6
- FWCI
- 10.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institute of Environmental Health Sciences (T32 ES007060-31A1)
- Husson University School of Pharmacy (2013-01)
- Fahs-Beck Fund for Research and Experimentation (2017-01)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- stimulant medication, amphetamine, methylphenidate, lisdexamfetamine, methamphetamine, ADHD medication, drug diversion, regional disparities, Hispanic population, pharmacoepidemiology, controlled substances, drug use trends, Southern United States, northeastern United States, ethnic disparities
- MeSH terms
- Central Nervous System Stimulants, Geography, Humans, United States, United States Food and Drug Administration, Prescriptions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.